Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
31
RAFA Quote, Financials, Valuation and Earnings
Last price:
$0.0300
Seasonality move
:
-4.21%
Day range:
$0.0300 - $0.0350
52-week range:
$0.0300 - $0.1790
Dividend yield:
0%
P/E ratio:
14.12x
P/S ratio:
0.29x
P/B ratio:
0.24x
Volume:
110K
Avg. volume:
18.8K
1-year change:
-60%
Market cap:
$2.5M
Revenue:
$9.1M
EPS (TTM):
--
Earnings Data
Next earnings date for RAFA
--
Most recent earnings per share
$0.00
Beat by $0.00
(May 21/2025)
Consensus Estimate
--
(May 21/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RAFA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/21/2025 | Q1 | -- | $278K | $0.00 | -- | -- |
| 12/31/2024 | Q4 | -- | $8.6M | $0.00 | -- | -- |
| 09/30/2024 | Q3 | -- | $185K | $0.00 | -- | -- |
Rafarma Pharmaceuticals, Inc. Earnings Questions
-
How Much did Rafarma Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Rafarma Pharmaceuticals, Inc. reported $278K worth of top line sales in its most recent quarter.
-
Did Rafarma Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Rafarma Pharmaceuticals, Inc. announced earnings per share of $0.00 which represents a beat of analyst forecast a -- per share.
-
Is Rafarma Pharmaceuticals, Inc. Profitable?
Rafarma Pharmaceuticals, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Rafarma Pharmaceuticals, Inc. EPS Next Year?
Rafarma Pharmaceuticals, Inc.'s earnings are forecast to grow from $0.00 per share to -- per share next year representing an increase of --.
-
When is Rafarma Pharmaceuticals, Inc.'s Earnings Date?
Currently, Rafarma Pharmaceuticals, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 22, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
